These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2798988)

  • 21. [Effects of theophylline on the respiratory system].
    Mutoh T; Horie T
    Kokyu To Junkan; 1992 Dec; 40(12):1165-72. PubMed ID: 1282731
    [No Abstract]   [Full Text] [Related]  

  • 22. [Controlled clinical study of doxophylline versus aminophylline in the treatment of acute cardiorespiratory insufficiency syndromes].
    Checchini M; Magni M; Scaglione M; Franzini C; Vaccarella A; Omboni E
    Minerva Cardioangiol; 1997 Apr; 45(4):185-90. PubMed ID: 9213834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum theophylline and ventilatory function in chronic obstructive lung disease. Comparison between two slow-release formulations of theophylline.
    Tantucci C; Grassi V; Verdecchia P; Cornelli U; Sorbini CA
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):560-4. PubMed ID: 3905630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of (dl) 3,7-dihydro-1,8-dimethyl-3-(2-methylbutyl)-1H-purine-2,6-dione on exercise-induced bronchospasm.
    Grassi C; Casali L; Rampulla C; Rossi A
    Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):297-302. PubMed ID: 7263107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of perphyllon A 13 on the cardiorespiratory function in healthy newborn infants and on those with adaptation disorders].
    Beutnagel H; Schöber JG; Schmidramsl H; Riegel K
    Z Geburtshilfe Perinatol; 1972 Apr; 176(2):125-32. PubMed ID: 5050500
    [No Abstract]   [Full Text] [Related]  

  • 26. Plant-based formulation in the management of chronic obstructive pulmonary disease: a randomized double-blind study.
    Murali PM; Rajasekaran S; Paramesh P; Krishnarajasekar OR; Vasudevan S; Nalini K; Lakshmisubramanian S; Deivanayagam CN
    Respir Med; 2006 Jan; 100(1):39-45. PubMed ID: 15905081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of doxofylline in asthma and COPD.
    Cazzola M; Matera MG
    Respir Med; 2020 Apr; 164():105904. PubMed ID: 32094104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety profile of doxofylline compared to theophylline in asthma: a meta-analysis.
    Rogliani P; Calzetta L; Ora J; Cazzola M; Matera MG
    Multidiscip Respir Med; 2019; 14():25. PubMed ID: 31388422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacodynamic study of theophylline-heptaminol acetate].
    Loubatieres A; Bouyard P
    Therapie; 1965; 20(3):797-808. PubMed ID: 5840887
    [No Abstract]   [Full Text] [Related]  

  • 30. [The comparative efficacy of the prolonged-action theophylline preparations Theopek and Euphylong in elderly patients with chronic obstructive lung diseases].
    Salikova VV; Nonikov VE; Belousov IuB
    Ter Arkh; 1993; 65(8):41-4. PubMed ID: 8211801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical trial of ventax (long-acting theophylline) in chronic obstructive bronchitis].
    Nikitina AV; Karpukhina EP; Lapygina MV; Evstratov AI
    Klin Med (Mosk); 1997; 75(1):40-1. PubMed ID: 9082058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of theophylline on respiratory function in patients with chronic obstructive lung disease].
    Sooronbaev TM; Altymysheva AT; Shabykeeva SB; Kadyraliev ZhK; Mirrakhimov MM
    Probl Tuberk Bolezn Legk; 2006; (7):13-6. PubMed ID: 16944706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease.
    Fontana G; Cresci F; Lo Sapio P; Panuccio P
    Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physiological and neuropsychological effects of theophylline in chronic obstructive pulmonary disease.
    Newman D; Tamir J; Speedy L; Newman JP; Ben-Dov I
    Isr J Med Sci; 1994 Nov; 30(11):811-6. PubMed ID: 7982769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Doxofylline: a "novofylline".
    Page CP
    Pulm Pharmacol Ther; 2010 Aug; 23(4):231-4. PubMed ID: 20380886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of theopek and saltos on cardiorespiratory system in bronchial asthma].
    Kirillov MM; Shapovalova TG; Riabova AIu; Smoliak SB; Bochkareva LE; Kurnosova OF; Kazban OG
    Klin Med (Mosk); 1999; 77(11):37-9. PubMed ID: 10635631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of theophylline-ethylendiamine on chronic pulmonary arterial hypertension secondary to chronic obstructive pulmonary disease.
    Panuccio P; Viroli L; Chelucci G; Cresci F
    G Ital Cardiol; 1984; 14 Suppl 1():74-6. PubMed ID: 6534771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral and intravenous pharmacokinetic profiles of doxofylline in patients with chronic bronchitis.
    Bologna E; Laganà A; Terracino D; Bolignari P; Biffignandi P
    J Int Med Res; 1990; 18(4):282-8. PubMed ID: 2227075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of the pharmacodynamic properties of the nicotinic ester of 7-(2-hydroxyethyl)-theophylline. I. Cardiocirculatory effects in normal subjects].
    De Gregorio G; Arcoraci A; Arrigo F
    Cardiol Prat; 1971 Aug; 22(4):271-80. PubMed ID: 5136159
    [No Abstract]   [Full Text] [Related]  

  • 40. Demonstrating the effect of theophylline treatment on diaphragmatic movement in chronic obstructive pulmonary disease patients by MR-fluoroscopy.
    Etlik O; Sakarya ME; Uzun K; Harman M; Temizoz O; Durmus A
    Eur J Radiol; 2004 Aug; 51(2):150-4. PubMed ID: 15246520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.